Infectious disease physician and Forbes contributor, Dr Judy Stone joined me to discuss the mcr-1 gene, the latest research and the serious implications. This interview took place on Jan. 3, 2016 on the Outbreak News This Week Radio Show with Robert Herriman.
Related:
- Staphylococcus aureus skin infections: Many fail to complete antibiotics resulting in new infections
- Bacteriophage-Encoded Protein Could Lead To New Antibiotics
- Travelers’ diarrhea antibiotics may bring greater risk for ‘superbug’ spread: Study
- Antibiotics for H. Pylori Decrease Gastric Cancer Risk
- Europe reports slight increase in cefixime resistance in gonorrhea
- WHO releases report on antibiotic resistance
- Ceftobiprole, single treatment for multiple common infections, to undergo Phase 3 clinical studies
- Fighting antibiotic-resistant infections with potent new nanodrug
- MRSA, CRE, other ‘superbugs’ account for good portion of healthcare-associated infections
- The Challenges We Face at the End of the Antibiotic Age Can Be Overcome by an Emerging New Vaccine Era
- European Medicines Agency looks at colistin use in animals following mcr-1 gene discovery
4 thoughts on “mcr-1 gene: An interview with Dr Judy Stone”